🇺🇸 FDA
Patent

US 11007171

Treatment and prevention of joint disorders

granted A61KA61K2300/00A61K31/047

Quick answer

US patent 11007171 (Treatment and prevention of joint disorders) held by Summit Innovation Labs LLC expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Summit Innovation Labs LLC
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2300/00, A61K31/047, A61K31/05, A61K31/12